share_log
Benzinga ·  05/02 17:10

ImmunityBio Shares Are Trading Higher After the Company Announced It Signed an Exclusive Global Arrangement With the Serum Institute of India. The Company Will Be Supplied With Bacillus Calmette-Guerin

ImmunityBio宣佈與印度血清研究所簽署獨家全球協議後,該公司股價走高。該公司將獲得 Calmette-Guerin 芽孢桿菌

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論